novel transcript, antisense to SHF

Novel transcript, antisense to SHF" refers to a natural antisense transcript (NAT) overlapping or adjacent to the sense transcript of the SHF gene. NATs are generally non-protein-coding RNAs transcribed from the DNA strand opposite to known genes. These molecules may regulate their sense counterparts and exert transcriptional and post-transcriptional gene regulatory roles through various mechanisms including transcriptional interference, RNA masking, double-stranded RNA formation leading to RNA interference-like effects, and local chromatin remodeling. Although many NATs have been implicated in gene regulation, the functional significance of individual, particularly uncharacterized, novel NATs often remains unclear and lacks evidence of being a direct therapeutic target. Moreover, the designation "novel transcript" indicates this entity may not be a canonical, established target, and its functional roles, clinical relevance, or aliases are not specifically described in primary knowledge databases. Critical note: - This entry lacks standardized nomenclature (full gene/protein/protein family name), has no recognized abbreviation, and is not established as a therapeutic target. There is not enough evidence to consider "novel transcript, antisense to SHF" as a validated drug target, receptor, or relevant biomarker. This entity represents a class (natural antisense transcript to a specific gene) rather than a single molecular target with clear functional or therapeutic annotation. - is_incorrect: true because the name is too generic, insufficiently specific, and does not represent an accepted, validated molecular target. The gene identifier ("ENSG00000309776") may not correspond to an annotated locus in major databases, indicating possible incompleteness or a placeholder status.

RNA masking Transcriptional interference dsRNA-dependent mechanisms Chromatin remodeling